Challenges in optimizing care in advanced breast cancer patients: Results of an international survey linked to the ABC1 consensus conference

Breast

Volumn 24, Issue 5, 2015, Pages 623-629

  McCutcheon, Susan ^a   Cardoso, Fatima ^b  

^a EISAI CO LTD   (Japan)

^b Champalimaud Cancer Center   (Portugal)

Author keywords

Advanced breast cancer; Consensus guidelines; Metastatic breast cancer; Survey

Indexed keywords

ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER THERAPY; CLINICAL PRACTICE; CONSENSUS DEVELOPMENT; FEMALE; HEALTH CARE QUALITY; HEALTH SURVEY; HUMAN; MALE; NURSING CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUESTIONNAIRE; TOTAL QUALITY MANAGEMENT; BREAST NEOPLASMS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; EVIDENCE BASED MEDICINE; HEALTH CARE SURVEY; HEALTH PERSONNEL ATTITUDE; INTERDISCIPLINARY COMMUNICATION; MULTIMODALITY CANCER THERAPY; ONCOLOGY NURSING; OUTCOME ASSESSMENT; PATHOLOGY; PATIENT CARE; PROCEDURES; STATISTICS AND NUMERICAL DATA;

ATTITUDE OF HEALTH PERSONNEL; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH CARE SURVEYS; HUMANS; INTERDISCIPLINARY COMMUNICATION; MALE; ONCOLOGY NURSING; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT CARE TEAM; PRACTICE GUIDELINES AS TOPIC;

EID: 84952639106     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2015.06.008     Document Type: Article

References (24)

1. World Health Organization, Mortality database. Available from: (access date: 27.09.13, via the International Agency for Research on Cancer: ). http://www-dep.iarc.fr/WHOdb/WHOdb.htm.
2. Cardoso F. Metastatic breast cancer patients: the forgotten heroes!. Breast 2009, 18:271-272.
3. Saphner T., Tormey D.C., Gray R. Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol 1996, 14:2738-2746.
4. Senkus E., Cardoso F., Pagani O. Time for more optimism in metastatic breast cancer?. Cancer Treat Rev 2013, 10.1016/j.ctrv.2013.09.015.
5. Wardley A. The need for advanced breast cancer treatment guidelines: results of an internet-based survey. Breast 2008, 17:275-281.
6. Mayer M., Grober S.E. Silent voices: women with advanced (metastatic) breast cancer share their needs and preferences for information, support and practical resources. A report from living beyond breast cancer 2006, 2014. Haverford, PA.
7. Mayer M., Huñis A., Oratz R., Glennon C., Spicer P., Caplan E., et al. Living with metastatic breast cancer: a global patient survey. Commun Oncol 2010, 7:406-412.
8. Cardoso F., Harbeck N., Fallowfield L., Kyriakides S., Senkus E. Locally recurrent or metastatic breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012, 23(suppl. 7):vii11-vii19.
9. National Comprehensive Cancer Network (NCCN) Clinical practice guidelines in oncology. Breast Cancer Vesion 2013, 3. Available from:, [accessed 30.09.13]. http://www.nccn.org/.
10. Harris L., Fritsche H., Mennel R., Norton L., Ravdin P., Taube S., et al. American Society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007, 25:5287-5312. for the American Society of Clinical Oncology.
11. National Comprehensive Cancer Network (NCCN) Clinical practice guidelines in oncology. Breast Cancer Vesion 2012, 1. Available from:, [accessed 08.06.12]. http://www.nccn.org/.
12. European School of Oncology (ESO)-MBC Task Force Metastatic breast cancer. Recommendations proposal from the European School of Oncology (ESO)-MBC Task Force. Breast 2007, 16:9-10.
13. Cardoso F., Bedard P.L., Winer E.P., Pagani O., Senkus-Konefka E., Fallowfield L.J., et al. International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy. J Natl Cancer Inst 2009, 101:1174-1181. for the ESO-MBC Task Force.
14. Pagani O., Senkus E., Wood W., Colleoni M., Cufer T., Kyriakides S., et al. International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?. J Natl Cancer Inst 2010, 102:456-463. for the ESO-MBC Task Force.
15. Cardoso F., Costa A., Norton L., Cameron D., Cufer T., Fallowfield L., et al. 1st International consensus guidelines for advanced breast cancer (ABC 1). Breast 2012, 21:242-252.
16. McCutcheon S., Cardoso F. The challenges in optimising care in patients with advanced breast cancer: results of an international survey. Breast 2013, 22(suppl. 3):S27.
17. EONS The European Oncology Nursing Society 2013, 2014.
18. Breast Centres Network, (accessed 17.10.13). http://www.breastcentresnetwork.org.
19. European School of Oncology ABC2 programme 2014.
20. Cardoso F., Costa A., Norton L., Senkus E., Aapro M., André F., et al. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2). Breast 2014, 23:489-502. for ESO and ESMO.
21. Cardoso F., Costa A., Norton L., Senkus E., Aapro M., André F., et al. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) dagger. Ann Oncol 2014, 25:1871-1888.
22. Hebert-Croteau N., Brisson J., Latreille J., Rivard M., Abdelaziz N., Martin G. Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer. J Clin Oncol 2004, 22:3685-3693.
23. Thomssen C., Marschner N., Untch M., Decker T., Hegewisch-Becker S., Jackisch C., et al. ABC1 Consensus Conference - a German perspective: first International Consensus Conference on Advanced Breast Cancer (ABC1), Lisbon, November 5, 2011. Breast Care (Basel) 2012, 7:52-59.
24. European Commission A European Commission initiative supporting quality in breast cancer care: breast cancer guidelines & quality assurance scheme for breast cancer services 2013, 2014.